tolebrutinib
sanofi
['tolebrutinib', 'sanofi']
media update: new two-year efficacy and safety data for #tolebrutinib , sanofi s investigational, brain-penetrant and bioactive #btk inhibitor, to be presented at ectrims 2022 - sanofi #multiplesclerosis 
#MultipleSclerosis #nrSPMS #ATA188 AtaraBio Trial. Army veteran. Life member of @PVA1946. My artwork handle is @Falken_Weg7